Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Cookson

Showing results (291-300 of 320) with videos related to

Pageof 32
Sort By:
Biorxiv : the Preprint Server for Biology|June 26, 2025
Dissecting the biological impact of <i>GBA1</i> mutations using multi-omics in an isogenic settingPilar Álvarez Jerez, Peter A Wild Crea, Dhairya Patel, et al.
Plos Genetics|June 26, 2007
Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humansJoyce van de Leemput, Jayanth Chandran, Melanie A Knight, et al.
Neurobiology of Aging|December 12, 2018
Genetic analysis of neurodegenerative diseases in a pathology cohortCornelis Blauwendraat, Olga Pletnikova, Joshua T Geiger, et al.
BMC Neurology|December 15, 2006
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDParastoo Momeni, Jennifer Schymick, Shushant Jain, et al.
Annals of Human Genetics|January 31, 2013
Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk LociPatrick Holton, Mina Ryten, Michael Nalls, et al.
NPJ Dementia|June 22, 2026
Haplotype-resolved DNA methylation at the <i>APOE</i> locus identifies allele-specific epigenetic signatures relevant to Alzheimer's disease riskRylee M Genner, Melissa Meredith, Kensuke Daida, et al.
Science Signaling|February 24, 2026
Temporal proteomic and phosphoproteomic dynamics during neuronal differentiation in the reference iPSC line KOLF2.1JYing Hao, Ziyi Li, Erika Lara, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Is <i>SORL1</i> a common genetic target across neurodegenerative diseases?: A multi-ancestry biobank scale assessmentMarzieh Khani, Sheila N Yeboah, Catalina Cerquera-Cleves, et al.
EMBO Molecular Medicine|July 26, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathiesMarc Emmenegger, Elena De Cecco, Marian Hruska-Plochan, et al.
Pageof 32

Showing results (291-300 of 320) with videos related to

Sort By:
Pageof 32
Biorxiv : the Preprint Server for Biology|June 26, 2025
Dissecting the biological impact of <i>GBA1</i> mutations using multi-omics in an isogenic settingPilar Álvarez Jerez, Peter A Wild Crea, Dhairya Patel, et al.
Plos Genetics|June 26, 2007
Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humansJoyce van de Leemput, Jayanth Chandran, Melanie A Knight, et al.
Neurobiology of Aging|December 12, 2018
Genetic analysis of neurodegenerative diseases in a pathology cohortCornelis Blauwendraat, Olga Pletnikova, Joshua T Geiger, et al.
BMC Neurology|December 15, 2006
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDParastoo Momeni, Jennifer Schymick, Shushant Jain, et al.
Annals of Human Genetics|January 31, 2013
Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk LociPatrick Holton, Mina Ryten, Michael Nalls, et al.
NPJ Dementia|June 22, 2026
Haplotype-resolved DNA methylation at the <i>APOE</i> locus identifies allele-specific epigenetic signatures relevant to Alzheimer's disease riskRylee M Genner, Melissa Meredith, Kensuke Daida, et al.
Science Signaling|February 24, 2026
Temporal proteomic and phosphoproteomic dynamics during neuronal differentiation in the reference iPSC line KOLF2.1JYing Hao, Ziyi Li, Erika Lara, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Is <i>SORL1</i> a common genetic target across neurodegenerative diseases?: A multi-ancestry biobank scale assessmentMarzieh Khani, Sheila N Yeboah, Catalina Cerquera-Cleves, et al.
EMBO Molecular Medicine|July 26, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathiesMarc Emmenegger, Elena De Cecco, Marian Hruska-Plochan, et al.
Pageof 32